Pharmacy benefit managers, pharmacies, and pharmacogenomic testing: prescription for progress?
Few would argue that the ability to match individual patients with the safest and most effective drugs and doses would be a major advance for clinical medicine. But while clinicians have been reluctant to routinely use pharmacogenomic analyses to guide their prescribing practices, pharmacy benefit managers and drugstores are proceeding with major pharmacogenetic initiatives.
Topol
Eric J
EJ
Scripps Translational Science Institute, Scripps Health, The Scripps Research Institute, and West Wireless Health Institute, La Jolla, CA 92037, USA. etopol@scripps.edu
D006801:Humans; D010594:Pharmacies / Q000639:trends*; D010595:Pharmacists / Q000639:trends*; D010597:Pharmacogenetics / Q000191:economics / Q000639:trends*; D010605:Pharmacy Administration; D010818:Practice Patterns, Physicians'; D057285:Precision Medicine / Q000191:economics / Q000639:trends; D055656:Prescriptions / Q000191:economics